Zong Q - Search Results

1

Self-assembled metal-phenolic network nanoparticles for delivery of a cisplatin prodrug for synergistic chemo-immunotherapy.

Zhang X, Zong Q, Lin T, Ullah I, Jiang M, Chen S, Tang W, Guo Y, Yuan Y, Du J. Zhang X, et al. Among authors: zong q. Biomater Sci. 2024 Jul 9;12(14):3649-3658. doi: 10.1039/d4bm00650j. Biomater Sci. 2024. PMID: 38857014

2

Size-Switchable Nanoparticles with Self-Destructive and Tumor Penetration Characteristics for Site-Specific Phototherapy of Cancer.

Wang K, Tu Y, Yao W, Zong Q, Xiao X, Yang RM, Jiang XQ, Yuan Y. Wang K, et al. Among authors: zong q. ACS Appl Mater Interfaces. 2020 Feb 12;12(6):6933-6943. doi: 10.1021/acsami.9b21525. Epub 2020 Feb 3. ACS Appl Mater Interfaces. 2020. PMID: 31951372

3

Polyprodrug with glutathione depletion and cascade drug activation for multi-drug resistance reversal.

Xiao X, Wang K, Zong Q, Tu Y, Dong Y, Yuan Y. Xiao X, et al. Among authors: zong q. Biomaterials. 2021 Mar;270:120649. doi: 10.1016/j.biomaterials.2020.120649. Epub 2021 Jan 6. Biomaterials. 2021. PMID: 33588139

4

Amplification of tumor oxidative stresses by Poly(disulfide acetal) for multidrug resistance reversal.

Zong Q, Wang K, Xiao X, Jiang M, Li J, Yuan Y, Wang J. Zong Q, et al. Biomaterials. 2021 Sep;276:121005. doi: 10.1016/j.biomaterials.2021.121005. Epub 2021 Jul 7. Biomaterials. 2021. PMID: 34252801

5

Sequential enzyme-activated macrotheranostic probe for selective tumor mitochondria targeting.

Ma D, Zong Q, Du Y, Yu F, Xiao X, Sun R, Guo Y, Wei X, Yuan Y. Ma D, et al. Among authors: zong q. Acta Biomater. 2021 Nov;135:628-637. doi: 10.1016/j.actbio.2021.08.002. Epub 2021 Aug 8. Acta Biomater. 2021. PMID: 34371167

6

Theranostic Heterodimeric Prodrug with Dual-Channel Fluorescence Turn-On and Dual-Prodrug Activation for Synergistic Cancer Therapy.

Jiang M, Wang K, Xiao X, Zong Q, Zheng R, Yuan Y. Jiang M, et al. Among authors: zong q. Adv Healthc Mater. 2021 Nov;10(21):e2101144. doi: 10.1002/adhm.202101144. Epub 2021 Aug 28. Adv Healthc Mater. 2021. PMID: 34453773

7

Dual-locking nanoprobe based on hemicyanine for orthogonal stimuli-triggered precise cancer imaging and therapy.

Zong Q, Zheng R, Xiao X, Jiang M, Li J, Yuan Y. Zong Q, et al. J Control Release. 2021 Oct 10;338:307-315. doi: 10.1016/j.jconrel.2021.08.042. Epub 2021 Aug 26. J Control Release. 2021. PMID: 34454962

8

Time-programmed activation of dual polyprodrugs for synergistic cascade oxidation-chemotherapy.

Liu Y, Jiang M, Tu Y, Wang K, Zong Q, Yuan Y. Liu Y, et al. Among authors: zong q. Biomaterials. 2021 Nov;278:121136. doi: 10.1016/j.biomaterials.2021.121136. Epub 2021 Sep 20. Biomaterials. 2021. PMID: 34562835

9

Tumor-Acidity and Bioorthogonal Chemistry-Mediated On-Site Size Transformation Clustered Nanosystem to Overcome Hypoxic Resistance and Enhance Chemoimmunotherapy.

Wang K, Jiang M, Zhou J, Liu Y, Zong Q, Yuan Y. Wang K, et al. Among authors: zong q. ACS Nano. 2022 Jan 25;16(1):721-735. doi: 10.1021/acsnano.1c08232. Epub 2022 Jan 3. ACS Nano. 2022. PMID: 34978422

10

Self-catalyzed tumor ferroptosis based on ferrocene conjugated reactive oxygen species generation and a responsive polymer.

Li J, Zong Q, Liu Y, Xiao X, Zhou J, Zhao Z, Yuan Y. Li J, et al. Among authors: zong q. Chem Commun (Camb). 2022 Mar 8;58(20):3294-3297. doi: 10.1039/d1cc06742g. Chem Commun (Camb). 2022. PMID: 35175251

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

308 results

Search Page

Filters